1988 …2024
If you made any changes in Pure, your changes will be visible here soon.

Projects 2005 2024

Active
Point-of-Care Systems
Cytomegalovirus
Cytomegalovirus Infections
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Genotype
Cytomegalovirus
Hearing
Randomized Controlled Trials
valganciclovir
Controlled Clinical Trials
Pharmacokinetics
Placebos
Safety
Paramyxoviridae Infections
Respiratory Tract Infections
Placebos
Oxygen
DAS181
Dry Powder Inhalers
Paramyxoviridae Infections
Infection
DAS181
Finished
Point-of-Care Systems
Conjugate Vaccines
Pneumococcal Vaccines
Streptococcus pneumoniae
Fever
Polymerase Chain Reaction
Enzyme-Linked Immunospot Assay
Peptide Mapping
Vaccines
Antigens
Caviid herpesvirus 2
glycoproteins
immunization
Trophoblasts
Infection
Tropism
Vaccines
Infection
Communicable Diseases
Pediatrics
Research
Immunomodulation
Vaccines
Immunomodulation
Vaccines
Cerebral Palsy
Case-Control Studies
Roseolovirus
Cytomegalovirus Infections
Cytomegalovirus
Vaccination
Cytomegalovirus
Vaccines
Safety
Simplexvirus glycoprotein B

Combined Genetic and Cytomegalovirus Screening to Improv

Schimmenti, L. A., Chen, S., Daly, K. & Schleiss, M. R.

March of Dimes Foundation

6/1/069/30/09

Project: Research project

Genetic Testing
Cytomegalovirus
Hearing
Genetically Modified Plants
Vaccines
Simplexvirus glycoprotein B